Disclosed in certain embodiments is a method of treating or preventing complications of airway control devices comprising administering to a patient having an airway control device a pharmaceutical composition comprising botulinum neurotoxin to one or more of the upper or lower aerodigestive secretory glands, the cricopharyngeus or the gastric or esophageal mucosal wall of the patient.